Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients
Clinical trial NCT00559624 · COMPLETED
Trial details
- NCT number
- NCT00559624
- Sponsor
- Advancell - Advanced In Vitro Cell Technologies, S.A.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.